Answers are grounded in this paper and cite their sources.
Retrospective review demonstrates reduced insertion-site bleeding and transfusions using kaolin gauze in percutaneous ECMO patients, indicating practical clinical utility.
Bleeding is a well described complication of percutaneous extracorporeal membrane oxygenation support (ECMO). In an effort to prevent ongoing percutaneous-cannula blood loss, we tried multiple methods to achieve hemostasis and have obtained the best results with QuikClot® Combat Gauze TM (Z-Medica Corp, Wallingford, CT). This product is made of kaolin, white alumina silicate clay, which initiates activation of the intrinsic clotting cascade. We reviewed our experience in 21 ECMO patients and found 5 patients who required 17 applications of QuikClot® Combat Gauze TM to percutaneous catheter insertion sites and demonstrated a significant reduction in both localized bleeding complications and the need for blood transfusion. QuikClot Combat Gauze TM, used for the dual purpose of a dressing and hemostatic agent, is a simple valuable method to control pericatheter bleeding in the ECMO population with demonstrated cost savings and clinical utility.
No takes yet. Share an insight, caveat, or question.
Kathleen M. Lamb (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: